Advertisement
Screener

HOOKIPA PHARMA INC. Net Income

HOOKIPA PHARMA INC. Net Income

HOOKIPA PHARMA INC. reported Net Income of -$15.43 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2025-05-15

  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$15.43M, a 207.26% decline year-over-year.
  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$24.95M.
  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for the quarter ending 2024-09-30 was -$13.84M.
  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for the quarter ending 2024-06-30 was -$19.09M.
  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for fiscal 2023 was -$81.58M.
  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for fiscal 2022 was -$64.92M.
  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for fiscal 2021 was -$75.67M.
  • HOOKIPA PHARMA INC. net income (loss) attributable to parent for fiscal 2020 was -$44.08M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2025-03-31-$15.43M
10-Q · filed 2025-05-15
-$40.37M
derived: sum of 2 quarters · filed 2025-05-15
-$54.22M
derived: sum of 3 quarters · filed 2025-05-15
-$73.31M
derived: sum of 4 quarters · filed 2025-05-15
2024-12-31-$24.95M
derived: 10-Q 12 month − 10-Q 9 month · filed 2025-05-15
-$38.79M
derived: sum of 2 quarters · filed 2025-05-15
-$57.88M
derived: sum of 3 quarters · filed 2025-05-15
-$43.50M
10-Q · filed 2025-05-15
-$43.50M
10-K · filed 2025-02-28
2024-09-30-$13.84M
10-Q · filed 2024-11-14
-$32.94M
derived: sum of 2 quarters · filed 2024-11-14
-$18.55M
10-Q · filed 2024-11-14
-$43.37M
derived: sum of 4 quarters · filed 2025-05-15
2024-06-30-$19.09M
10-Q · filed 2024-11-14
-$4.71M
10-Q · filed 2024-08-08
-$29.53M
derived: sum of 3 quarters · filed 2025-05-15
-$48.60M
derived: sum of 4 quarters · filed 2025-05-15
2024-03-31$14.38M
10-Q · filed 2025-05-15
-$10.44M
derived: sum of 2 quarters · filed 2025-05-15
-$29.50M
derived: sum of 3 quarters · filed 2025-05-15
-$47.52M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$24.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$43.88M
derived: sum of 2 quarters · filed 2025-02-28
-$61.90M
derived: sum of 3 quarters · filed 2025-02-28
-$81.58M
10-K · filed 2025-02-28
2023-09-30-$19.07M
10-Q · filed 2024-11-14
-$37.08M
derived: sum of 2 quarters · filed 2024-11-14
-$56.76M
10-Q · filed 2024-11-14
-$69.07M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30-$18.02M
10-Q · filed 2024-11-14
-$37.70M
10-Q · filed 2024-08-08
-$50.01M
derived: sum of 3 quarters · filed 2025-02-28
-$68.29M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$19.68M
10-Q · filed 2024-11-14
-$31.99M
derived: sum of 2 quarters · filed 2025-02-28
-$50.27M
derived: sum of 3 quarters · filed 2025-02-28
-$66.63M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$12.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$30.59M
derived: sum of 2 quarters · filed 2025-02-28
-$46.95M
derived: sum of 3 quarters · filed 2025-02-28
-$64.92M
10-K · filed 2025-02-28
2022-09-30-$18.28M
10-Q · filed 2023-11-09
-$34.64M
derived: sum of 2 quarters · filed 2023-11-09
-$52.60M
10-Q · filed 2023-11-09
-$73.84M
derived: sum of 4 quarters · filed 2024-03-22
2022-06-30-$16.36M
10-Q · filed 2023-11-09
-$34.32M
10-Q · filed 2023-08-10
-$55.56M
derived: sum of 3 quarters · filed 2024-03-22
-$75.60M
derived: sum of 4 quarters · filed 2024-03-22
2022-03-31-$17.97M
10-Q · filed 2023-11-09
-$39.20M
derived: sum of 2 quarters · filed 2024-03-22
-$59.24M
derived: sum of 3 quarters · filed 2024-03-22
-$76.40M
derived: sum of 4 quarters · filed 2024-03-22
2021-12-31-$21.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
-$41.27M
derived: sum of 2 quarters · filed 2024-03-22
-$58.43M
derived: sum of 3 quarters · filed 2024-03-22
-$75.67M
10-K · filed 2024-03-22
2021-09-30-$20.04M
10-Q · filed 2022-11-14
-$37.19M
derived: sum of 2 quarters · filed 2022-11-14
-$54.43M
10-Q · filed 2022-11-14
-$66.91M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$17.15M
10-Q · filed 2022-11-14
-$34.39M
10-Q · filed 2022-08-11
-$46.87M
derived: sum of 3 quarters · filed 2022-11-14
-$60.45M
derived: sum of 4 quarters · filed 2022-11-14
2021-03-31-$17.24M
10-Q · filed 2022-11-14
-$29.71M
derived: sum of 2 quarters · filed 2022-11-14
-$43.30M
derived: sum of 3 quarters · filed 2022-11-14
-$50.39M
derived: sum of 4 quarters · filed 2022-11-14
2020-12-31-$12.47M
10-K · filed 2021-03-18
-$26.06M
derived: sum of 2 quarters · filed 2021-11-10
-$33.16M
derived: sum of 3 quarters · filed 2021-11-10
-$44.08M
10-K · filed 2023-03-15
2020-09-30-$13.59M
10-Q · filed 2021-11-10
-$20.68M
derived: sum of 2 quarters · filed 2021-11-10
-$31.61M
10-Q · filed 2021-11-10
-$41.85M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$7.09M
10-Q · filed 2021-11-10
-$18.02M
10-Q · filed 2021-08-12
-$28.26M
derived: sum of 3 quarters · filed 2021-11-10
-$39.65M
derived: sum of 4 quarters · filed 2021-11-10
2020-03-31-$10.93M
10-Q · filed 2021-11-10
-$21.17M
derived: sum of 2 quarters · filed 2021-11-10
-$32.55M
derived: sum of 3 quarters · filed 2021-11-10
-$44.63M
derived: sum of 4 quarters · filed 2021-11-10
2019-12-31-$10.24M
10-K · filed 2021-03-18
-$21.63M
derived: sum of 2 quarters · filed 2021-03-18
-$33.71M
derived: sum of 3 quarters · filed 2021-03-18
-$43.04M
10-K · filed 2022-03-24
2019-09-30-$11.38M
10-K · filed 2021-03-18
-$23.46M
derived: sum of 2 quarters · filed 2021-03-18
-$32.79M
10-Q · filed 2020-11-12
-$34.69M
derived: sum of 4 quarters · filed 2021-03-18
2019-06-30-$12.08M
10-K · filed 2021-03-18
-$21.41M
10-Q · filed 2020-08-13
-$23.30M
derived: sum of 3 quarters · filed 2021-03-18
-$27.25M
derived: sum of 4 quarters · filed 2021-03-18
2019-03-31-$9.33M
10-K · filed 2021-03-18
-$11.22M
derived: sum of 2 quarters · filed 2021-03-18
-$15.17M
derived: sum of 3 quarters · filed 2021-03-18
-$20.99M
derived: sum of 4 quarters · filed 2021-03-18
2018-12-31-$1.89M
10-K · filed 2020-03-19
-$5.84M
derived: sum of 2 quarters · filed 2020-03-19
-$11.66M
derived: sum of 3 quarters · filed 2020-03-19
-$16.24M
10-K · filed 2021-03-18
2018-09-30-$3.95M
10-K · filed 2020-03-19
-$9.77M
derived: sum of 2 quarters · filed 2020-03-19
-$14.35M
10-Q · filed 2019-11-12
2018-06-30-$5.82M
10-K · filed 2020-03-19
-$10.39M
10-Q · filed 2019-08-12
2018-03-31-$4.57M
10-K · filed 2020-03-19
2017-12-31-$12.72M
10-K · filed 2020-03-19